by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

UCSF Radiopharmaceutical Facility Warning Letter Details

Warning Letter

UCSF Radiopharmaceutical Facility

Recipient Title Director, Radiopharmaceutical Facility, 185 Berry St. Ste. 350 San Francisco , CA 94107-9107 United States

Issue DateApril 13, 2026

FEI Number3005947301

Violations2

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

UCSF Radiopharmaceutical Facility FDA Warning Letter, April 13, 2026